Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
äŒæ¥ã³ãŒãNSRX
äŒç€ŸåNasus Pharma Ltd
äžå Žæ¥Aug 13, 2025
æé«çµå¶è²¬ä»»è
ãCEOãTeleman (Dan)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Aug 13
æ¬ç€Ÿæåšå°Yigal Alon 65
éœåžTEL AVIV-YAFO
蚌åžååŒæNASDAQ OMX â NASDAQ Basic Amex
åœIsrael
éµäŸ¿çªå·- -
é»è©±çªå·97237326616
ãŠã§ããµã€ãhttps://www.nasuspharma.com
äŒæ¥ã³ãŒãNSRX
äžå Žæ¥Aug 13, 2025
æé«çµå¶è²¬ä»»è
ãCEOãTeleman (Dan)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã